a public good project by the
Synthesis
Company
of California

© 2026

Kirsten Muri Boberg | doi.page

0 works0 citations0 h-index

Kirsten Muri Boberg

Oslo University Hospital(NO)University of Oslo(NO)

Publications by Year

Research Areas

Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Gallbladder and Bile Duct Disorders, Cholangiocarcinoma and Gallbladder Cancer Studies, Pediatric Hepatobiliary Diseases and Treatments

Most-Cited Works

→ Simplified criteria for the diagnosis of autoimmune hepatitis†(2008)1,846 cited
→ Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)(2016)1,366 cited
→ Diagnosis and Management of Primary Sclerosing Cholangitis(2009)1,214 cited
→ The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease(2015)794 cited
→ Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue(2010)542 cited
→ Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis(2017)505 cited

→ Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer(2013)

429 cited

→ Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis(2013)393 cited

→ High-Dose Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: A 5-Year Multicenter, Randomized, Controlled Study(2005)392 cited

→ Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease(2016)374 cited